Coronavirus disease 2019 (COVID-19): Multisystem review of pathophysiology

Ann Med Surg (Lond). 2021 Sep;69:102745. doi: 10.1016/j.amsu.2021.102745. Epub 2021 Aug 23.ABSTRACTCoronavirus disease-19 (COVID-19) pandemic is associated with high morbidity and mortality. COVID-19, which is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2), affects multiple organ systems through a myriad of mechanisms. Afflicted patients present with a vast constellation of symptoms, from asymptomatic disease to life-threatening complications. The most common manifestations pertain to mild pulmonary symptoms, which can progress to respiratory distress syndrome and venous thromboembolism. However, in patients with renal failure, life-threatening cardiac abnormalities can ensue. Various mechanisms such as viral entry through Angiotensin receptor (ACE) affecting multiple organs and thus releasing pro-inflammatory markers have been postulated. Nevertheless, the predictors of various presentations in the affected population remain elusive. An ameliorated understanding of the pathology and pathogenesis of the viral infection has led to the development of variable treatment options, with many more that are presently under trial. This review article discusses the pathogenesis of multiple organ involvement secondary to COVID-19 infection in infected patients.PMID:34457265 | PMC:PMC8381637 | DOI:10.1016/j.amsu.2021.102745
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research

Related Links:

Dysfunctional breathing, hypocapnia, and myalgic encephalomyelitis/chronic fatigue syndrome were seen in symptomatic patients post-acute COVID-19 despite normal chest imaging and pulmonary function.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
Two days after the first case of the new Omicron Covid-19 variant was officially confirmed in Massachusetts, the head of the state's largest hospital system stressed the importance of vaccines and masks.
Source: Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Two years into the pandemic, what's next?
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Prioritizing workforce well-being is a key driver of business success. The COVID-19 pandemic changed the world more than any event in recent history, significantly impacting the health and well-being of our workforce and economy. The inextricable link between individual health and productivity, business performance and economic prosperity is clear, and now is the time for employers to actively engage and support the mental and physical health of employees. In a recent survey by The Economist Intelligence…
Source: Health Care News Headlines - Category: Health Management Authors: Source Type: news
Chris EdwardsThe main weapons against COVID-19 are the vaccines developed by Moderna and BioNTech after a decade of their research into mRNA technologies. That research was supported by more than $3 billion of private angel investment and venture capital.Democrats and Republicans both support medical research funding, and Republicans tout the Trump administration ’s Operation Warp Speed. But governments were not the key to mRNA development. Instead, we can thank the leaders and scientists at Moderna and BioNTech and the suppliers of private capital to them, as I discusshere andhere.TheWall Street Journal &r...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
Fueled by new evidence that wildfire smoke can carry living microbes and is associated with a local increase in COVID-19 cases, scientists wonder if smoke might spread infectious diseases and worsen their effects
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
Jeffrey A. SingerPolitical polarization hinders progress against the COVID-19 pandemic.Political polarization may explain why, after former President Trump called the off ‐​label use of the anti‐​malarial drug hydroxychloroquine a “game‐​changer” in the battle against COVID-19 (randomized controlled trials found that isnot the case), public health officials and the mainstream press appear uninterested in the off ‐​label use of any other drugs as therapeutics against a COVID infection.For example, impressive data from randomized controlled trials show the off ‐​label use of the off‐​...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
As scientists hunt for alternatives for people who can't access vaccines for COVID-19, they are searching underwater in unexpected places to study the therapeutic potential of edible marine algae.WebMD Health News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Infectious Diseases News Source Type: news
In updated guidance, IDSA suggests that healthcare personnel caring for patients with suspected or known COVID-19 use eye protection as part of appropriate personal protective equipment.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of vaccines against COVID-19.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Coronavirus | COVID-19 | Internal Medicine | Pandemics | Pathology | Pulmonary Thromboembolism | Renal Failure | Respiratory Medicine | SARS | Thrombosis